320 related articles for article (PubMed ID: 20836877)
1. Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease.
Kohl Z; Regensburger M; Aigner R; Kandasamy M; Winner B; Aigner L; Winkler J
BMC Neurosci; 2010 Sep; 11():114. PubMed ID: 20836877
[TBL] [Abstract][Full Text] [Related]
2. Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.
Kandasamy M; Rosskopf M; Wagner K; Klein B; Couillard-Despres S; Reitsamer HA; Stephan M; Nguyen HP; Riess O; Bogdahn U; Winkler J; von Hörsten S; Aigner L
PLoS One; 2015; 10(2):e0116069. PubMed ID: 25719447
[TBL] [Abstract][Full Text] [Related]
3. Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.
Smail S; Bahga D; McDole B; Guthrie K
Chem Senses; 2016 Mar; 41(3):221-32. PubMed ID: 26783111
[TBL] [Abstract][Full Text] [Related]
4. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease.
Kohl Z; Kandasamy M; Winner B; Aigner R; Gross C; Couillard-Despres S; Bogdahn U; Aigner L; Winkler J
Brain Res; 2007 Jun; 1155():24-33. PubMed ID: 17512917
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model.
Moraes L; de Moraes Mello LE; Shimabukuro MK; de Castro Batista CM; Mendez-Otero R
Neuropathology; 2009 Apr; 29(2):140-7. PubMed ID: 18713310
[TBL] [Abstract][Full Text] [Related]
6. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
Ransome MI; Hannan AJ
Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
[TBL] [Abstract][Full Text] [Related]
7. Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1.
Fedele V; Roybon L; Nordström U; Li JY; Brundin P
Neuroscience; 2011 Jan; 173():76-81. PubMed ID: 20807561
[TBL] [Abstract][Full Text] [Related]
8. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
Gil JM; Mohapel P; Araújo IM; Popovic N; Li JY; Brundin P; Petersén A
Neurobiol Dis; 2005 Dec; 20(3):744-51. PubMed ID: 15951191
[TBL] [Abstract][Full Text] [Related]
9. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
10. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
11. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment.
Lazic SE; Grote HE; Blakemore C; Hannan AJ; van Dellen A; Phillips W; Barker RA
Eur J Neurosci; 2006 Apr; 23(7):1829-38. PubMed ID: 16623840
[TBL] [Abstract][Full Text] [Related]
12. Striatal oligodendrogliogenesis and neuroblast recruitment are increased in the R6/2 mouse model of Huntington's disease.
McCollum MH; Leon RT; Rush DB; Guthrie KM; Wei J
Brain Res; 2013 Jun; 1518():91-103. PubMed ID: 23623813
[TBL] [Abstract][Full Text] [Related]
13. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
14. Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome.
Bianchi P; Bettini S; Guidi S; Ciani E; Trazzi S; Stagni F; Ragazzi E; Franceschini V; Bartesaghi R
Exp Neurol; 2014 Jan; 251():1-11. PubMed ID: 24192151
[TBL] [Abstract][Full Text] [Related]
15. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.
Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ
J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
17. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice.
Reiner A; Del Mar N; Deng YP; Meade CA; Sun Z; Goldowitz D
J Comp Neurol; 2007 Dec; 505(6):603-29. PubMed ID: 17948889
[TBL] [Abstract][Full Text] [Related]
18. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
19. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
Dufour BD; McBride JL
Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
[TBL] [Abstract][Full Text] [Related]
20. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
